COUNTRIES | The Maldives Launches Thalassaemia-Specialized Hospital and 10-Year Strategic Disease Plan
TIF Drives Major Milestone in Thalassemia Care

With the invaluable support of the Thalassaemia International Federation, the Maldives embarks on a pioneering journey by announcing the establishment of a thalassaemia-dedicated hospital and the implementation of a visionary 10-year strategic plan to advance disease-specific care.
On October 15th, 2024, the Maldives celebrated a major milestone in the progress against thalassaemia, with the Health Minister, Mr. Abdulla Nazim Ibrahim, signing an official agreement on behalf of the Maldivian government for the establishment of a thalassaemia-dedicated Hospital in the island of Hulhumale’. The announcement was made during a ceremony celebrating the launch of the 10-year Thalassaemia Master Plan, unveiled by the Vice President of the Republic of Maldives. The plan outlines specific strategies and key actions for the prevention, control, and management of thalassaemia in the country.
This development follows a longstanding partnership between local healthcare authorities and the Maldives Blood Services (MBS) with the Thalassaemia International Federation (TIF) for over 15 years. TIF is currently working on signing a Memorandum of Understanding (MoU) with the MBS to enhance thalassaemia awareness and prevention through expertise exchange and the modernization of public blood services.
According to the latest MBS data, the Maldives has 666 children registered with thalassaemia. To support these children, the government spends over MVR 30 million (approximately USD 2 million) annually on medicines and other lifesaving resources.
TIF proudly applauds these significant steps forward and is committed to furthering efforts to improve the quality of life for those affected by thalassaemia in the Maldives. This development marks a significant achievement in healthcare for the nation and sets a precedent for comprehensive care and international cooperation in the fight against genetic blood disorders.